CJC-1295 + Ipamorelin
Also known as: Growth Hormone Secretagogue Blend
This combination consists of a GHRH analog (CJC-1295) and a selective ghrelin receptor agonist (Ipamorelin). Together, they are researched for their synergistic effect on endogenous growth hormone secretion.
Molecular Properties
Molecular Formula
Various (Combination)
Molecular Weight
Not applicable
CAS Number
Not available
Research History
CJC-1295 was engineered for extended half-life, while Ipamorelin was developed for specific GHS-R stimulation without typical side effects like increased hunger. Combining them has become a standard model for studying GH pulsatility.
Studied Mechanisms
CJC-1295 increases the number of secretory pulses of growth hormone, while Ipamorelin increases the amplitude of those pulses. This dual action bypasses somatostatin inhibition.
Storage Reference
-20°C, lyophilized
Handling Reference
Reconstitute with bacteriostatic water